Eikon Therapeutics, Inc. Common Stock
- EIKN
- NASDAQ
- Biotechnology
- Clinical-Stage Biopharma
- Drug Discovery/Development
$7.42
Today −1.59%Quote Oct 16, 2026, 08:00 PM UTC
−13.72%over the last month
Max drawdown −25.2%From 1-month high −17.4%3 months −23.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$401.7M
Quote Oct 16
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$14.00
+88.7% from here
Floor
$7.02
5.4% below price
Where the price sits
1 analyst
Analyst range, low to high
$5.00$23.00
- Price $7.42
- Resistance $7.44
- Consensus $14.00
The price is right under resistance. Analysts' average target sits about 89% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about EIKNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
384